Net Cash Provided by (Used in) Investing Activities of Transcode Therapeutics, Inc. from 31 Mar 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Transcode Therapeutics, Inc. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Mar 2021 to 31 Dec 2024.
  • Transcode Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was $3,836, a 70% increase year-over-year.
  • Transcode Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $21,761, a 39% increase from 2023.
  • Transcode Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $35,609, a 65% increase from 2022.
  • Transcode Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $100,919, a 60% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)

Transcode Therapeutics, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $21,761 +$13,848 +39% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $35,609 +$65,310 +65% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $100,919 +$150,901 +60% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $251,820 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY

Transcode Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $3,836 +$9,060 +70% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $12,896 +$17,761 +58% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2023 Q3
Q1 2022 $30,657 +$44,644 +59% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $75,301 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.